Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Cerlin Roberts at c.roberts@oxfordglobal.co.uk

2017 Drug Discovery Congress Confirmed Speakers Include:

Markus Haeberlein, Vice President, Discovery
Alkermes, Inc.

Nick Terrett, European Chemistry Lead and Scientific Associate Vice President
MSD Research GmbH

Alastair Lawson, Research Fellow and Vice President Structural Biology
UCB

Klaus Bæk Simonsen, Vice President and Head of Discovery Chemistry, DMPK and Molecular Screening
Lundbeck

Christopher Gibson, Co-Founder and Chief Executive Officer
Recursion Pharmaceuticals

Jim Xu, Executive Director of Corporate Development/Strategic Planning
MSD

Markus Schade, Scientific Director
Grünenthal GmbH

Garry Pairaudeau, Head of External Sciences
AstraZeneca

Georgia McGaughey, Senior Director, Modeling & Informatics
Vertex Pharmaceuticals

Patrick Kleyn, Director, Innovation and Entrepreneurship Incubation
EMD Serono

Peter Juhasz, Director, Mechanisms and Pathways
Biogen

Thomas Vorherr, Director Peptide Discovery
Novartis Institutes for BioMedical Research

Stephen J. Shuttleworth, Chief Operating Officer and Chief Scientific Officer
Karus Therapeutics, Ltd.

Phil Kym, Director, Medicinal Chemistry
AbbVie

Guido Koch, Director, Global Discovery Chemistry
Novartis

Peter Dandliker, Director, Affinity Screening & Preclinical Pharmacology
Merck

Jing Li, Director of Pharmacology, Screening and Triage
MSD

John Feder, Associate Director, Genome Biology
Bristol Myers Squibb

Constance Höfer, Drug Development Advisor
Chemcollect GmbH

Jan Spanholtz, Chief Scientific Officer
Glycostem Therapeutics

Andrea van Elsas, Chief Scientific Officer
Aduro Biotech Europe

Tauseef R. Butt, President and Chief Executive Officer
Progenra Inc

Nils Hansen, Chief Executive Officer
Vipergen ApS

Frank Osterkamp, Director Chemistry & Analytics
3B Pharmaceuticals GmbH

Armin Bauer, Director of External Partnerships
Sanofi-Aventis Deutschland GmbH

Herman van Vlijmen, Head, Computational Chemistry, Discovery Sciences EU
Janssen

Daniel Zwilling, Director of CNS Discovery
Circuit Therapeutics

Jorrit Hornberg, Director, Discovery Safety
AstraZeneca

Melanie Leveridge, Director, Screening Profiling & Mechanistic Biology UK
GlaxoSmithKline

Anders Hogner, Head, Computational Chemistry, Cardiovascular and Metabolic Disease
Astra Zeneca

Tamara Maes, Chief Scientific Officer and Vice President
Oryzon Genomics S.A.

Pierre Ducrot, Head of Molecular Modeling and Cheminformatics
Institut de Recherches Servier

Jonathan Mason, Senior Research Fellow and Head CADD
Heptares Therapeutics Ltd.

Nicolas Fischer, Head of Research
Novimmune

Niclas Nilsson, Head of R&D Open Innovation
LEO Pharma

Werngard Czechtizky, Head of Medicinal Chemistry
Sanofi

Rod Hubbard, Senior Fellow
Vernalis

and

Professor
University of York

Andrew Payne, Senior Group Leader
UCB

Frédéric Berst, Senior Research Investigator, Global Discovery Chemistry
Novartis Institutes for BioMedical Research

Christian Fischer, Principal Scientist, Chemistry
MSD

Thierry Dorval, HCS – Group Leader, Biotechnology Chemical-Biology
Servier

Manuela Duerr, Project Leader Immuno-Oncology
Pieris

Francois Sautel, Open Innovation Project Leader
Institut de Recherche Pierre Fabre

Henrik Möbitz, Senior Research Investigator, Global Discovery Chemistry
Novartis Institutes for BioMedical Research

Guido Zaman, Managing Director & Head of Biology
Netherlands Translational Research Center B.V.

Ton Rijnders, Scientific Director
Lygature

and

Head of European Screening Center
IMI European Lead Factory

Fabio Gasparri, Head of Cell Assay Technologies
Nerviano Medical Sciences

Paul Andrews, Director of Operations, National Phenotypic Screening Centre
University of Dundee

Stefano Gustincich, Deputy Director for Life Sciences and the DIrector of the Department of Neuroscience and Brain Technologies
Istituto Italiano di Tecnologia

Emma Shanks, Head of Screening and HNSCC Research Group
The Beatson Institute for Cancer Research

Óscar Villacañas, Chief Scientific Officer
Intelligent Pharma

Josep Prous, Jr., Executive Director
BioInfoGate (a Prous Group company)

Montse del Fresno, Senior Product Manager, Preclinical Solutions
Clarivate Analytics

Dimitrios Tzalis, Chief Executive Officer
Taros Chemicals GmbH & Co. KG